Göran Ahlgren

affiliated with the university
More filtering options
  1. 2018
  2. Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial

    Göran M. Ahlgren, Flodgren, P., Tammela, T. L. J., Kellokumpu-Lehtinen, P., Borre, M., Angelsen, A., Iversen, J. R., Sverrisdottir, A., Jonsson, E. & Sengelov, L., 2018, In : European Urology. 73, 6, p. 870-876

    Research output: Contribution to journalArticle

  3. 2017
  4. Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

    Thomsen, F. B., Sandin, F., Garmo, H., Lissbrant, I. F., Göran Ahlgren, Van Hemelrijck, M., Adolfsson, J., Robinson, D. & Stattin, P., 2017, In : European Urology. 72, 6, p. 920-928

    Research output: Contribution to journalArticle

  5. Long-term functional outcomes after radical cystectomy with ileal bladder substitute: does the definition of continence matter?

    Fredrik Liedberg, Göran Ahlgren, Baseckas, G., Gudjonsson, S., Håkansson, U., Lindquist, S., Löfgren, A., Oliver Patschan, Siller, C. & Gottfrid Sjödahl, 2017, In : Scandinavian Journal of Urology. 51, 1, p. 44-49 6 p.

    Research output: Contribution to journalArticle

  6. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): An open-label, phase 3, randomised controlled trial

    Azzouzi, A. R., Vincendeau, S., Barret, E., Cicco, A., Kleinclauss, F., van der Poel, H. G., Stief, C. G., Rassweiler, J., Salomon, G., Solsona, E., Alcaraz, A., Tammela, T. T., Rosario, D. J., Gomez-Veiga, F., Ahlgren, G., Benzaghou, F., Gaillac, B., Amzal, B., Debruyne, F. M. J., Fromont, G. & 2 othersGratzke, C. & Emberton, M., 2017, In : The Lancet Oncology. 18, 2, p. 181-191

    Research output: Contribution to journalArticle

  7. Prostatacancercentrum - navet i framtidens prostatacancersjukvård

    Ola Bratt, Göran Ahlgren, Börjedahl, A. C., Lissbrant, I. F. & Waller, C., 2017, In : Lakartidningen. 114, 5

    Research output: Contribution to journalArticle

  8. 2016
  9. Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden

    Svensson, J., Andersson, E., Persson, U., Edekling, T., Ovanfors, A. & Göran Ahlgren, 2016 Jul 3, In : Scandinavian Journal of Urology. 50, 4, p. 286-291

    Research output: Contribution to journalArticle

  10. Reduction of quality of life in prostate cancer patients: experience among 6200 men in the Nordic countries

    Fosså, S. D., Bengtsson, T., Borre, M., Göran Ahlgren, Rannikko, A. & Dahl, A. A., 2016, In : Scandinavian Journal of Urology. 50, 5, p. 330-337 8 p.

    Research output: Contribution to journalArticle

  11. 2015
  12. (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.

    Kjölhede, H., Göran Ahlgren, Almquist, H., Fredrik Liedberg, Lyttkens, K., Ohlsson, T. & Ola Bratt, 2015, In : World Journal of Urology. 33, 11, p. 1749-1752

    Research output: Contribution to journalArticle

  13. Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.

    Fizazi, K., Abrahamsson, P-A., Göran Ahlgren, Bellmunt, J., Castellano, D., Culine, S., de Wit, R., Gillessen, S., Gschwend, J. E., Hamdy, F., James, N., McDermott, R., Miller, K., Wiegel, T., Wirth, M. & Tombal, B., 2015, In : European Urology. 67, 5, p. 904-912

    Research output: Contribution to journalReview article

  14. Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts

    Ahmed, K., Khan, R., Mottrie, A., Lovegrove, C., Abaza, R., Ahlawat, R., Ahlering, T., Ahlgren, G., Artibani, W., Barret, E., Cathelineau, X., Challacombe, B., Coloby, P., Khan, M. S., Hubert, J., Michel, M. S., Montorsi, F., Murphy, D., Palou, J., Patel, V. & 19 othersPiechaud, P-T., Van Poppel, H., Rischmann, P., Sanchez-Salas, R., Siemer, S., Stoeckle, M., Stolzenburg, J-U., Terrier, J-E., Thueroff, J. W., Vaessen, C., Van der Poel, H. G., Van Cleynenbreugel, B., Volpe, A., Wagner, C., Wiklund, P., Wilson, T., Wirth, M., Witt, J. & Dasgupta, P., 2015, In : BJU International. 116, 1, p. 93-101

    Research output: Contribution to journalArticle

  15. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer

    Ternov, K. K., Krag Jakobsen, A., Ola Bratt & Göran Ahlgren, 2015, In : Scandinavian Journal of Urology. 49, 2, p. 115-119

    Research output: Contribution to journalArticle

  16. 2014
  17. (18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.

    Kjölhede, H., Göran Ahlgren, Almquist, H., Fredrik Liedberg, Lyttkens, K., Ohlsson, T. G. & Ola Bratt, 2014, In : World Journal of Urology. 32, 4, p. 965-970

    Research output: Contribution to journalArticle

  18. 2013
  19. Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer

    Elisabeth Rasmusson, Gunnlaugsson, A., Blom, R., Bojrk-Eriksson, T., Per Nilsson, Göran Ahlgren, Jönsson, C., Karin Johansson & Kjellén, E., 2013, In : Radiation Oncology. 8, 271.

    Research output: Contribution to journalArticle

  20. 2012
  21. Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.

    Kjölhede, H., Göran Ahlgren, Almquist, H., Fredrik Liedberg, Lyttkens, K., Ohlsson, T. G. & Ola Bratt, 2012, In : BJU International. 110, 10, p. 1501-1506

    Research output: Contribution to journalArticle

  22. 2011
  23. NATION-WIDE POPULATION-BASED STUDY ON 15-YEAR MORTALITY IN PROSTATE CANCER ACCORDING TO RISK CATEGORIES IN THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN

    Stattin, P., Sandin, F., Göran Ahlgren, Bratt, O., Damber, J. E., Hugosson, J., Pettersson, B., Robinson, D., Tornblom, M., Karlsson, S., Andren, O., Bill-Axelson, A., Widmark, A., Egevad, L., Ehrnström, R., Adolfsson, J., Lambe, M. & Johansson, J. E., 2011, In : European Urology Supplements. 10, 2, p. 324-325

    Research output: Contribution to journalPublished meeting abstract

  24. 2010
  25. System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer.

    Swartling, J., Axelsson, J., Göran Ahlgren, Kälkner, K. M., Nilsson, S., Svanberg, S., Katarina Svanberg & Andersson-Engels, S., 2010, In : Journal of Biomedical Optics. 15, 5, 058003.

    Research output: Contribution to journalArticle

  26. 2009
  27. Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.

    Ola Bratt, Häggman, M., Göran Ahlgren, Nordle, O., Björk, A. & Damber, J-E., 2009, In : British Journal of Cancer. 101, p. 1233-1240

    Research output: Contribution to journalArticle

  28. 2008
  29. 2007
  30. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden

    Adolfsson, J., Garmo, H., Varenhorst, E., Göran Ahlgren, Ahlstrand, C., Andren, O., Bill-Axelson, A., Ola Bratt, Damber, J-E., Hellstrom, K., Hellstrom, M., Holmberg, E., Holmberg, L., Hugosson, J., Johansson, J-E., Petterson, B., Tornblom, M., Widmark, A. & Stattin, P., 2007, In : Scandinavian Journal of Urology and Nephrology. 41, 6, p. 456-477

    Research output: Contribution to journalArticle

  31. 2005
  32. 2002
  33. Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial

    Aus, G., Abrahamsson, P-A., Göran Ahlgren, Hugosson, J., Lundberg, S., Schain, M., Schelin, S. & Pedersen, K., 2002, In : BJU International. 90, 6, p. 561-566

    Research output: Contribution to journalArticle

  34. 1999
  35. Prognostic factors in prostate cancer with special reference to the effect of hormonal therapy

    Göran Ahlgren, 1999, Department of Urology, Malmö University Hospital, 205 02 Malmö, Sweden. 152 p.

    Research output: ThesisDoctoral Thesis (compilation)